NCT00302991View on ClinicalTrials.gov

Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Epilepsy
Trial Locations (1)

Unknown

Barcelona

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00302991 - Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA) | Biotech Hunter | Biotech Hunter